CVS Group plc commences an Equity Buyback Plan for 7,174,031 shares, representing 10.04% of its issued share capital, under the authorization approved on November 18, 2025.
CVS Group plc (LSE:CVSG) commences share repurchases on May 26, 2026, under the program mandated by the shareholders in the Annual General Meeting held on November 18, 2025. As per the mandate, the company is authorized to repurchase up to 7,174,031 ordinary shares, representing 10.04% of its issued share capital. The minimum price (exclusive of expenses) which may be paid for each ordinary share is 0.2p and the maximum price which may be paid for each ordinary share is the higher an amount equal to 105% of the average of the middle market quotations for an ordinary share as derived from the London Stock Exchange Daily Official List of the UK Listing Authority for the five business days immediately preceding the day on which the ordinary share is contracted to be purchased and an amount equal to the higher of the price of the last independent trade of an ordinary share and the current highest independent bid for an ordinary share as derived from the London Stock Exchange Trading System. The program is financed via financial resources of the Company. The purpose of the program is to increase earnings per share. The shares purchased may either be cancelled or held as treasury shares, which may then be cancelled, sold for cash, or used to meet the company?s obligations under its employee share schemes. The authority shall expire at the conclusion of the next Annual General Meeting or December 31, 2026 whichever is earlier. As of November 18, 2025, the company had 71,433,195 ordinary shares in issue.
On May 26, 2026, the company announced a share repurchase program. Under the program, the company will repurchase £50 million worth of its shares. The purpose of the program is to both return surplus capital to shareholders and reduce the Group's share capital. The repurchased shares will be cancelled. The program is valid till November 24, 2026.
CVS Group plc is a United Kingdom-based provider of veterinary services with operations in the United Kingdom and Australia. The Company is focused on providing clinical services to its clients and their animals. It operates approximately 470 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, it operates Laboratories and an online retail business (Animed Direct). The Company's Companion Animal division forms the majority of its Veterinary Practices division. Its Laboratories division provides diagnostic services and in-practice desktop analyzers to both CVS and third-party practices and employs a national courier network to facilitate the collection and timely processing of samples from practices across the United Kingdom. Animed Direct is focused on supplying pet food and prescription and non-prescription medicine directly to customers.
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
CVS Group plc commences an Equity Buyback Plan for 7,174,031 shares, representing 10.04% of its issued share capital, under the authorization approved on November 18, 2025.
